| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |